The University of Chicago Header Logo

Connection

Mark J. Ratain to Oligodeoxyribonucleotides, Antisense

Back to Details
This is a "connection" page, showing publications Mark J. Ratain has written about Oligodeoxyribonucleotides, Antisense.
Mark J. Ratain
Connection Strength
0.202
Oligodeoxyribonucleotides, Antisense
  1. Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer. Clin Cancer Res. 2001 May; 7(5):1214-20.
    View in: PubMed
    Score: 0.202
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.